David Moreira Appointed Vice President of Marketing, Menicon America

NAGOYA, Japan, July 20, 2010 – -Menicon focusing on expanding its presence in the custom contact lens
market-

Menicon Co., Ltd. announced on July 20 the appointment of David Moreira
as Vice President of Marketing for Menicon America Inc. Moreira will report
to Jonathan Jacobson, President of Menicon America.
Moreira joins [...]

Bristol-Myers Squibb Foundation’s SECURE THE FUTURE(R) Works to Reduce the Impact of HIV and Tuberculosis Epidemic in Africa

Community-Based Programs Confront Challenges Associated With Dual Epidemic -

VIENNA, July 20, 2010 – Bristol-Myers Squibb Company (NYSE: BMY) and the Bristol-Myers Squibb
Foundation announced at the XVIII International AIDS Conference in Vienna the
community-based projects that it is currently supporting in resource-poor
regions across Africa to help combat the challenge of HIV and tuberculosis
co-infection.
[...]

Frost & Sullivan: Consumers Becoming Increasingly Savvy About Marine and Algae Oil Omega-3 Ingredients

LONDON, July 20, 2010 – The flood of scientific evidence on omega-3 eicosapentaenoic
acid/docosahexaenoic acid (EPA/DHA) has significantly buoyed the credibility
of polyunsaturated fatty acids (PUFAs) as vital functional ingredients.
Heightened consumer awareness has had a telling effect on the healthy growth
charts of the marine and algae oil omega-3 ingredients market.

(Logo: photos.prnewswire.com/prnh/20081117/FSLOGO)
[...]

Operational Agility Forum Launched – New Thought Leadership Forum to Focus on the Challenge of Achieving Agility in Business Operations

Senior IT and Business Professionals Create New Forum to Focus on the Challenge of Achieving Operational Agility

LONDON, July 20, 2010 – A new interest group called the Operational Agility Forum has been
established by senior information technology and business professionals who
represent some of the largest users of IT in the UK. Members of the forum
work [...]

PSI and Partners Join Call for Male Circumcision Scale Up

WHO, US Global AIDS Coordinator, and noted academic highlight ways to maximize impact of the life-saving intervention at the International AIDS Conference in Vienna

VIENNA, July 20, 2010 – The U.S. Global AIDS Coordinator Ambassador Eric Goosby and the World
Health Organization's Director of HIV, TB, and Malaria, Africa Regional
Office, Dr. David Okello, joined PSI (Population [...]

ARUP Laboratories Ink Partnership to Offer deCODE ProstateCancer(TM) Test

U.S. Laboratories and Physicians Will be Able to use Their ARUP Accounts to Order deCODE's Test for Assessing Risk of Prostate Cancer

Reykjavik, ICELAND, and Salt Lake City, UTAH, July 20, 2010 – deCODE genetics and ARUP Laboratories today announced a partnership
through which ARUP will offer deCODE's DNA-based prostate cancer risk
assessment test to its clients [...]

Health Robotics’ CytoCare Continues European Expansion With Grifols and Vall d’Hebron University Hospital

BOZEN, Sud-Tirol, Italy, July 20, 2010 – Health Robotics today announced that it recently signed agreements to
grant exclusive CytoCare distribution rights in Spain and Portugal to
world-leading IV Therapy company Grifols S.A., and to install the first-ever
Cancer Therapy Robot in Spain at Vall d'Hebron University Hospital in
Barcelona in November 2010.

"We are [...]

MEDcounselor Drug Information Now Available on ISMP’s ConsumerMedSafety.org

MEDcounselor's Drug Information, Drug IDentifier and Drug Interactions Modules Help Consumers Take Medications Safely, Avoid Errors

TAMPA, Florida, July 20, 2010 – Gold Standard/Elsevier, developer of drug information and
medication management solutions, announced today that the Institute for Safe
Medication Practices (ISMP) has licensed MEDcounselor (
www.goldstandard.com/pages/medCounselor.html?epm=1_1) Drug
Information, Drug IDentifer and Drug Interaction modules for its consumer
website, ConsumerMedSafety.org [...]

MarketsandMarkets Partners With Centre of Business Intelligence (CBI) for its Market Research and Product Forecasting Summit

DALLAS, July 20, 2010 – Event Date- July 26 – 27, 2010

Location- Philadelphia, PA
About the event:
Join your colleagues and peers to discuss optimizing, executing and
improving market research to drive accurate sales forecasting. This is a
unique opportunity for pharmaceutical executives to hear best [...]

Abbott’s PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint

PROGRESS is the First Study to Present 48-Week Efficacy Results for this Combination When Used in Treatment-Naive Patients with HIV

VIENNA, July 19, 2010 – Abbott (NYSE: ABT) today presented 48-week findings comparing an HIV
regimen of its protease inhibitor (PI), Kaletra(R) (lopinavir/ritonavir), and
Merck's integrase inhibitor, Isentress(R) (raltegravir), to a traditional HIV
regimen of Kaletra and the [...]

Bill Gates: World Has Historic Opportunity to ‘Change the Face of AIDS’

In Keynote Speech to AIDS Conference, Gates Outlines Roadmap to Reduce Annual New HIV Infections 90% by 2031

VIENNA, July 19, 2010 – Speaking to the 18th International AIDS Conference today, Bill Gates
called on all countries to keep up the fight against HIV/AIDS, saying the
world has an historic opportunity to "change the face of AIDS." [...]

Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance

Terms include initial US$1.25 million ELITech equity investment in Corgenix with options for US$3 million total, plus distribution agreement and diagnostic system co-development

DENVER and PARIS, July 19, 2010 – Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide
developer and marketer of diagnostic test kits, and the ELITech Group, a
Paris, France-based, privately held group of [...]

Amira Pharmaceuticals Hits Two Development Milestones Related to FLAP Inhibitor Program

SAN DIEGO, July 19, 2010 – "Amira Pharmaceuticals, Inc. announced today that its FLAP
(5-lipoxygenase-activating protein) program, which is partnered with
GlaxoSmithKline, has achieved two clinical development milestones."

These milestones are related to the successful progression of the program
to Phase 2 studies, which explore the use of the Amira discovered FLAP
inhibitor in patients [...]

International Organizations Agree to Take Concerted Action to End Pediatric HIV/AIDS

"No child should enter this world infected with HIV."
VIENNA, July 19, 2010 – A global alliance of international organizations, including the heads of
UNICEF, UNAIDS and The Global Fund to Fight AIDS, Tuberculosis and Malaria as
well as other NGOs including the Pan African Treatment Access Movement,
Health GAP, Ugandan Pediatric Association and the Global AIDS Alliance [...]